BANK OF AMERICA CORP /DE/
BankPosition in HOWL — Werewolf Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in HOWL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$112,140
-$108,257 QoQ
Shares Held
311,502
+17.7% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 45 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in HOWL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. HOWL ranks #306 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in HOWL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,140 | 311,502 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $220,397 | 264,583 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $467,606 | 737,550 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,605,674 | 1,830,292 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,320,635 | 2,129,024 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,044,252 | 2,103,142 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,076,733 | 2,078,875 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,565,879 | 2,153,717 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,239,716 | 2,147,425 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,189,612 | 1,881,113 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,090,871 | 2,096,081 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,278,316 | 1,531,924 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,666,057 | 1,529,855 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,981,803 | 1,531,463 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,143,862 | 1,533,592 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $15,684 | 3,478 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,017 | 2,694 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $98,194 | 22,317 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $336,635 | 28,265 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $10,621 | 619 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,492 | 487 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||